Liver stiffness assessed by transient elastography in patients with β thalassaemia major
Journal Title: Annals of Hepatology - Year 2016, Vol 15, Issue 3
Abstract
Rationale for the study. This cross-sectional multicenter study was conducted to investigate any difference in liver stiffness measurements (LSM), evaluated by transient elastography, between patients affected by β thalassaemia major, with and without hepatitis C virus (HCV) infection, and healthy blood donors (controls). Secondary aim was to assess any correlation between transient elastography and serum ferritin, liver magnetic resonance imaging (MRI) T2* or superconductive quantum interference device (SQUID) liver susceptometry values. Materials and methods. The study involved three centers. Transient elastography and MRI T2* examinations were performed in all centers. SQUID liver susceptometry was performed in center1 and center2. T-test for independent data or Mann-Whitney U test was used to analyse differences between two groups. Univariate Pearson’s r coefficient was used to test correlations between liver stiffness measurements and all other variables. Results. In a study with 119 patients and 183 controls, patients who had never been infected with HCV showed significantly higher LSMs than controls [5.7 (95% CI, 5.2-6.2) kPa vs. 4.3 (95% CI, 4.1-4.4) kPa, p < 0.0001]. A moderate correlation between LSMs and ferritin values, adjusted for gender and age, was found in patients (r = 0.49, p < 0.0001) but not in controls (r = -0.22, p = 0.6). No correlation between LSMs and MRI T2* or SQUID liver susceptometry values was observed. In conclusion, compared to controls β thalassaemia major patients had a significant increase in LSMs independently from HCV infection.
Authors and Affiliations
Giovanna Ferraioli, Raffaella Lissandrin, Carmine Tinelli, Luigia Scudeller, Federico Bonetti, Mabel Zicchetti, Filomena Longo, Mauro Murgia, Stefano Bernuzzi, Marco Zecca, Paolo Casula, Antonio Piga, Carlo Filice
Keywords
Related Articles
- EP ID EP78582
- DOI 10.5604/16652681.1198817
- Views 127
- Downloads 0
Glisson’s capsule blistering after hyperthermic intraperitoneal chemotherapy
Hypertermic intraperitoneal chemotherapy is a treatment option after cytorreduction of certain types of malignancies with peritoneal spread. Blistering of the Glisson’s capsule has not been previously reported as a conse...
Rapid identification system of frontal dysfunction in subclinical hepatic encephalopathy
Introduction and aim. Liver disease is associated with cognitive dysfunction also at early stages, and minimal hepatic encephalopathy, affecting 20-70% of patients, is frequently under-recognized. The main purpose of th...
Treatment regimens for non-alcoholic fatty liver disease
With the growing epidemic of obesity and diabetes, more attention has been placed on metabolic syndrome and its associated hepatic manifestation, non-alcoholic fatty liver disease (NAFLD). Within the spectrum of clinico...
D-MELD does not predict post-liver transplantation survival: a single-center experience from Brazil
Background. The D-MELD score was designed to prevent donor-recipient matches with a high risk of unfavorable outcome. The main objective of the present study was to assess the predictive value of the DMELD score for 1-mo...
Faldaprevir, pegylated interferon, and ribavirin for treatment-naïve HCV genotype-1: pooled analysis of two phase 3 trials
Introduction & aim. Faldaprevir is a potent once-daily (q.d.) hepatitis C virus (HCV) NS3/4A protease inhibitor. The STARTVerso1and STARTVerso2 phase 3 studies evaluated faldaprevir plus peginterferon alfa-2...